Characteristics of 357 patients with methicillin-sensitive S. aureus bacteraemia (SAB) and a deep infection focus categorized according to duration of rifampicin therapy.

Patients with alcoholism, acute or chronic liver diseases, lack of deep infection foci, MRSA bacteraemia (n = 6) or a fatal outcome within 3 days have been excluded. Values are expressed as n (%). NS = non-significant. Short rifampicin therapy 1–13 days. Long rifampicin therapy ≥14 days.A Classification according to McCabe and Jackson [32].B Severity of illness at blood culture collection time point.C Infectious diseases specialist (IDS) consultation.D Fluoroquinolone: levo-, moxi- or ciprofloxacin.E Aminoglycoside: tobramycin or gentamicin.F Deep infection focus within 90 days follow-up.G SAB relapse within 90 days of follow-up.Characteristics of 357 patients with methicillin-sensitive S. aureus bacteraemia (SAB) and a deep infection focus categorized according to duration of rifampicin therapy.